Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Accelerate Diagnostics Inc

AXDX
Current price
1.16 USD -0.12 USD (-9.38%)
Last closed 1.28 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 27 388 992 USD
Yield for 12 month +52.61 %
1Y
3Y
5Y
10Y
15Y
AXDX
21.11.2021 - 28.11.2021

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona. Address: 3950 South Country Club Road, Tucson, AZ, United States, 85714

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.5 USD

P/E ratio

Dividend Yield

Current Year

+12 059 000 USD

Last Year

+12 752 000 USD

Current Quarter

+2 921 000 USD

Last Quarter

+3 000 000 USD

Current Year

+2 550 000 USD

Last Year

+3 303 000 USD

Current Quarter

+723 000 USD

Last Quarter

+606 000 USD

Key Figures AXDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -44 812 000 USD
Operating Margin TTM -347.69 %
PE Ratio
Return On Assets TTM -73.6 %
PEG Ratio -0.55
Return On Equity TTM
Wall Street Target Price 1.5 USD
Revenue TTM 12 168 000 USD
Book Value -1.18 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 3.9 %
Dividend Yield
Gross Profit TTM 3 303 000 USD
Earnings per share -3.97 USD
Diluted Eps TTM -3.97 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics AXDX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AXDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 12.07.2023
Dividend Date

Stock Valuation AXDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 3.7515
Price Sales TTM 1.5953
Enterprise Value EBITDA -0.9089
Price Book MRQ

Financials AXDX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AXDX

For 52 weeks

0.73 USD 8.72 USD
50 Day MA 1.04 USD
Shares Short Prior Month 387 339
200 Day MA 3.04 USD
Short Ratio 10.37
Shares Short 424 430
Short Percent 2.79 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

446.34 USD Microsoft Corporation -3.37 (-0.75%)
Detailed analytics

ETF funds


S

SLICHA

203.95 CHF UBS SLI A-dis -0.06 (-0.02%)
Detailed analytics

Metals


Gold

2339.94 USD Gold +11.09 (+0.48%)
Detailed analytics